Olof Breuer Selected Research

2',6'-pipecoloxylidide

1/2007

Pharmacokinetics of ropivacaine in patients with chronic end-stage liver disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Olof Breuer Research Topics

Disease

1	Genetic Risk Score 01/2022
1	Candidemia 01/2022
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2022
1	Critical Illness (Critically Ill) 01/2022
1	Hyperthyroidism 11/2014
1	End Stage Liver Disease 01/2007

Drug/Important Bio-Agent (IBA)

1	Blood Proteins (Serum Proteins)IBA 01/2022
1	LithiumIBA 01/2022
1	NitrogenIBA 01/2022
1	Caspofungin (Cancidas)FDA Link 01/2022
1	Urea (Carbamide)FDA LinkGeneric 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 11/2014
1	Insulin (Novolin)FDA Link 11/2014
1	LDL CholesterolIBA 11/2014
1	LDL Receptors (LDL Receptor)IBA 11/2014
1	Triglycerides (Triacylglycerol)IBA 11/2014
1	Dietary CholesterolIBA 11/2014
1	fibroblast growth factor 21IBA 11/2014
1	3- ((3,5- dibromo- 4- (4- hydroxy- 3- (1- methylethyl)phenoxy)phenyl)amino)- 3- oxopropanoic acidIBA 11/2014
1	lipoprotein cholesterolIBA 11/2014
1	Apolipoproteins B (ApoB)IBA 11/2014
1	Bile Acids and Salts (Bile Acids)IBA 11/2014
1	CholesterolIBA 11/2014
1	Lipoprotein(a)IBA 11/2014
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 11/2014
1	Ropivacaine (Naropin)FDA LinkGeneric 01/2007
1	2',6'-pipecoloxylidideIBA 01/2007